Express Scripts (ERSX) Increases Sales, Shipments in Q1

Express Scripts Holding Company (NASDAQ:ESRX), the largest pharmacy benefit manager in the United States, is up in early trading despite missing the consensus estimate for first quarter earnings due to increased prescription volume and much higher revenue than expected. Revenue for the first quarter of 2012 increased 9.4 percent to total $12.1 billion, greatly surpassing analyst expectations of $11.5 billion in sales. The revenue growth . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers


0